Retatrutide is a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By activating these receptors, Retatrutide https://finnianletl894291.develop-blog.com/43548889/tirzepatide-a-promising-new-treatment-for-obesity